myasthenic syndrome


Also found in: Thesaurus, Medical.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.myasthenic syndrome - a disease seen in patients with lung cancer and characterized by weakness and fatigue of hip and thigh muscles and an aching back; caused by antibodies directed against the neuromuscular junctions
disease of the neuromuscular junction - a disease characterized by impairment of neuromuscular junctions
References in periodicals archive ?
Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), anti-MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3.
Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.
M2 EQUITYBITES-May 7, 2019-US FDA approves first ever paediatric treatment for Lambert-Eaton myasthenic syndrome
Global Banking News-May 7, 2019-US FDA approves first ever paediatric treatment for Lambert-Eaton myasthenic syndrome
M2 PHARMA-May 7, 2019-US FDA approves first ever paediatric treatment for Lambert-Eaton myasthenic syndrome
Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve.
Repetitive nerve stimulation (RNS) was originally widely applied in the functional evaluation of neuromuscular junctions (NMJs), where it became a routine examination of the NMJ diseases such as myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome.[2] Since the first description by Mulder et al .
He is currently involved in an ongoing study for Lambert-Eaton myasthenic syndrome (LEMS).
We had nine patients with PNS; two patients had subacute cerebellar degeneration (SCD); three had Stiff-person syndrome (SPS); one had Lambert-Eaton myasthenic syndrome (LEMS); and the remaining patient had sensory neuropathy (SN).
(6,7) Isolated clinical comorbidities * Laryngomalacia * Subglottic stenosis * Subdural hematoma * Central nervous system malformations including Arnold Chiari malformation * Arthrogryposis * Facial dysmorphic features * Velopharyngeal insufficiency * Hypotonia/myopathy * Ear deformities/sensorineural hearing loss Syndromic associations * Robinow syndrome * Goldenhar syndrome * Down syndrome * Williams syndrome * DiGeorge syndrome * Mobius syndrome * Charcot-Marie-Tooth disease (type 1, 1b and 2) * JS-X syndrome * Hereditary neuralgic amyotrophy * Congenital myasthenic syndrome
Lambert-Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disorder resulting from the development of auto-antibodies against voltage-gated calcium channels (VGCCs) in pre-synaptic terminals (1).
Lambert-Eaton myasthenic syndrome antibodies (voltage gate calcium channel (VGCC) antibodies) were also negative.